Adagio Medical Holdings, Inc. (ADGM)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Revenue from contract with customer, excluding assessed tax | - | - | 132 | |
| Selling, general, and administrative | 2,404 | 3,485 | 2,926 | |
| Research and development | 1,971 | 3,659 | 1,217 | |
| Cost of revenue | 342 | 253 | 414 | |
| Total cost of revenue and operating expenses | 4,717 | 7,397 | 4,557 | |
| Loss from operations | -4,717 | -7,397 | -4,425 | |
| Other income (expense), net | 102 | -46 | 72 | |
| Interest income | 102 | 164 | 166 | |
| Interest expense | 720 | 662 | 435 | |
| Warrant liabilities fair value adjustment | 141 | -38 | -4,973 | |
| Convertible notes fair value adjustment | -1,427 | -190 | -3,255 | |
| Total other income (expense), net | 770 | -316 | 8,031 | |
| Net loss | -3,947 | -7,713 | 3,606 | |
| Foreign currency translation adjustment | -39 | -61 | -9 | |
| Comprehensive loss | -3,986 | -7,774 | 3,597 | |
| Earnings per share, basic | -0.26 | -0.5 | 0.18 | |
| Earnings per share, diluted | -0.35 | -0.51 | 0.02 | |
| Weighted average number of shares outstanding, basic | 15,381,565 | 15,375,521 | 14,057,636 | |
| Weighted average number of shares outstanding, diluted | 15,381,565 | 15,375,521 | 16,057,636 | |